Lockman, Shahin <br/><br/>
Response to antiretroviral therapy after a single, peripartum dose of nevirapine.  [electronic resource] 

 -  The New England journal of medicine  Jan 2007 
 - 135-47 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1533-4406 
<br/><br/><label>Standard No.: </label>10.1056/NEJMoa062876  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Anti-Retroviral Agents--administration & dosage<br/>Double-Blind Method<br/>Drug Resistance, Viral--genetics<br/>Drug Therapy, Combination<br/>Female<br/>Genotype<br/>HIV Infections--drug therapy<br/>HIV-1--genetics<br/>Humans<br/>Infant, Newborn<br/>Infectious Disease Transmission, Vertical--prevention & control<br/>Kaplan-Meier Estimate<br/>Labor, Obstetric<br/>Mutation<br/>Nevirapine--administration & dosage<br/>Pregnancy<br/>Pregnancy Complications, Infectious--drug therapy<br/>Pregnancy Trimester, Third<br/>Proportional Hazards Models<br/>Prospective Studies<br/>RNA, Viral--blood<br/>Risk Factors<br/>Treatment Failure<br/>Viral Load<br/>Zidovudine--therapeutic use